Karyopharm Therapeutics (KPTI) PT Lowered to $14 at Wedbush

February 25, 2019 6:19 AM EST
Get Alerts KPTI Hot Sheet
Price: $6.10 -0.16%

Rating Summary:
    11 Buy, 3 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 13 | New: 52
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten lowered the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $14.00 (from $19.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change